La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Acumen Pharmaceuticals Dividende
Dividende contrôle des critères 0/6
Acumen Pharmaceuticals does not have a record of paying a dividend.
Informations clés
n/a
Rendement du dividende
n/a
Ratio de distribution
Rendement moyen de l'industrie | 2.0% |
Prochaine date de paiement du dividende | n/a |
Date ex-dividende | n/a |
Dividende par action | n/a |
Résultat par action | -US$1.08 |
Prévisions de rendement du dividende à 3 ans | 0% |
Mises à jour récentes des dividendes
Pas de mise à jour
Recent updates
Does Acumen Pharmaceuticals (NASDAQ:ABOS) Have A Healthy Balance Sheet?
Aug 05Acumen Pharmaceuticals: Healthy Cash Runway And Market Potential In Alzheimer's
Jul 30Is Acumen Pharmaceuticals (NASDAQ:ABOS) Weighed On By Its Debt Load?
Apr 21Companies Like Acumen Pharmaceuticals (NASDAQ:ABOS) Are In A Position To Invest In Growth
Sep 21We're Not Very Worried About Acumen Pharmaceuticals' (NASDAQ:ABOS) Cash Burn Rate
Feb 01Acumen Pharmaceuticals (NASDAQ:ABOS) Is In A Good Position To Deliver On Growth Plans
Oct 16Acumen Pharma at 11-month high on rivals’ Alzheimer’s data
Sep 28Acumen Pharmaceuticals initiated at buy at H.C. Wainwright on Alzheimer's candidate
Jun 30We Think Acumen Pharmaceuticals (NASDAQ:ABOS) Can Afford To Drive Business Growth
May 10We're Not Very Worried About Acumen Pharmaceuticals' (NASDAQ:ABOS) Cash Burn Rate
Jan 07Acumen Pharmaceuticals (NASDAQ:ABOS) Is In A Good Position To Deliver On Growth Plans
Oct 01Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: Insufficient data to determine if ABOS's dividends per share have been stable in the past.
Dividende croissant: Insufficient data to determine if ABOS's dividend payments have been increasing.
Rendement des dividendes par rapport au marché
Acumen Pharmaceuticals Rendement des dividendes par rapport au marché |
---|
Segment | Rendement du dividende |
---|---|
Entreprise (ABOS) | n/a |
25% du marché (US) | 1.5% |
25% du marché (US) | 4.4% |
Moyenne du secteur (Biotechs) | 2.0% |
Prévisions des analystes dans 3 ans (ABOS) | 0% |
Dividende notable: Unable to evaluate ABOS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Dividende élevé: Unable to evaluate ABOS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Bénéfice distribué aux actionnaires
Couverture des revenus: Insufficient data to calculate ABOS's payout ratio to determine if its dividend payments are covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as ABOS has not reported any payouts.